Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
Fremantle-based Virex Pharma operates in Biotechnology Research. Ownership is publicly held; it publishes at virexpharma.com. It holds one address on record, all in Australia. The record counts 1 person. Tagged respiratory, nanotechnology and covid-19. One Australian registration (ABN) is a confirmed match. It is listed alongside eight similar brands, mostly in Pharmaceutical Manufacturing.
ABN13641983182
| VIREX PHARMA LIMITED | ABN 13641983182 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Virex Pharma is developing novel nanotechnology formulations of an antiviral drug for the treatment of infections caused by Respiratory Syncytial Virus (RSV), COVID-19 and Dengue virus
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
1 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
One Western Australia entity on the ABR. VIREX PHARMA LIMITED (ABN 13 641 983 182), high confidence.
The record holds 1 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.
One address on record, Australia only. Primary: 28, 13 Cantonment Street, Fremantle, WA 6160.
None linked to this brand.
11 tags on the brand's own list, among them respiratory, nanotechnology and covid-19.
Eight peer profiles on record: Creso Pharma and Ab Initio Pharma.